These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10545984)

  • 1. Inflammatory thoughts about glioma gene therapy.
    Kielian T; Hickey WF
    Nat Med; 1999 Nov; 5(11):1237-8. PubMed ID: 10545984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials.
    Dewey RA; Morrissey G; Cowsill CM; Stone D; Bolognani F; Dodd NJ; Southgate TD; Klatzmann D; Lassmann H; Castro MG; Löwenstein PR
    Nat Med; 1999 Nov; 5(11):1256-63. PubMed ID: 10545991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local inflammation and devascularization--in vivo mechanisms of the "bystander effect" in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma.
    Floeth FW; Shand N; Bojar H; Prisack HB; Felsberg J; Neuen-Jacob E; Aulich A; Burger KJ; Bock WJ; Weber F
    Cancer Gene Ther; 2001 Nov; 8(11):843-51. PubMed ID: 11773974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-TK.
    Cowsill C; Southgate TD; Morrissey G; Dewey RA; Morelli AE; Maleniak TC; Forrest Z; Klatzmann D; Wilkinson GW; Löwenstein PR; Castro MG
    Gene Ther; 2000 Apr; 7(8):679-85. PubMed ID: 10800091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
    Mizuno M; Ryuke Y; Yoshida J
    Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
    Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell death in primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU.
    Maleniak TC; Darling JL; Lowenstein PR; Castro MG
    Cancer Gene Ther; 2001 Aug; 8(8):589-98. PubMed ID: 11571537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator.
    Yamaguchi T; Okada T; Takeuchi K; Tonda T; Ohtaki M; Shinoda S; Masuzawa T; Ozawa K; Inaba T
    Gene Ther; 2003 Mar; 10(5):375-85. PubMed ID: 12601392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of murine brain tumors by direct inoculation of concentrated high titer-recombinant retrovirus harboring the herpes simplex virus thymidine kinase gene.
    Tamura K; Tamura M; Ikenaka K; Yoshimatsu T; Miyao Y; Nanmoku K; Shimizu K
    Gene Ther; 2001 Feb; 8(3):215-22. PubMed ID: 11313793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene therapy for cerebral tumors: use of an adenovirus in the glioma C6 rat model].
    Maron A
    Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):377-80. PubMed ID: 10992887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
    Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study.
    Immonen A; Vapalahti M; Tyynelä K; Hurskainen H; Sandmair A; Vanninen R; Langford G; Murray N; Ylä-Herttuala S
    Mol Ther; 2004 Nov; 10(5):967-72. PubMed ID: 15509514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cells producing recombinant retrovirus with thymidine kinase gene from Herpes simplex virus suitable for human cancer gene therapy.
    Hlavatý J; Hlubinová K; Bies J; Altaner C
    Neoplasma; 1999; 46(6):329-34. PubMed ID: 10732860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
    Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
    Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebral injection of adenovirus harboring the HSVtk gene combined with ganciclovir administration: toxicity study in nonhuman primates.
    Driesse MJ; Vincent AJ; Sillevis Smitt PA; Kros JM; Hoogerbrugge PM; Avezaat CJ; Valerio D; Bout A
    Gene Ther; 1998 Aug; 5(8):1122-9. PubMed ID: 10326036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
    Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy.
    Loimas S; Toppinen MR; Visakorpi T; Jänne J; Wahlfors J
    Cancer Gene Ther; 2001 Feb; 8(2):137-44. PubMed ID: 11263529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sitimagene ceradenovec, a gene therapeutic for the treatment of glioma.
    Düzgünes N
    Curr Opin Mol Ther; 2008 Apr; 10(2):187-95. PubMed ID: 18386231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy.
    Ketola A; Määttä AM; Pasanen T; Tulimäki K; Wahlfors J
    Int J Mol Med; 2004 May; 13(5):705-10. PubMed ID: 15067374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.